Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 819 results for "eli lilly"

Traders Sell Shares of Eli Lilly and on Strength (LLY)
Mideast Time

Traders Sell Shares of Eli Lilly and on Strength (LLY)

Traders sold shares of Eli Lilly and (NYSE:LLY) on strength during trading on Thursday, Analyst RN reports. $56.61 million flowed into the stock on the tick-up and $105.66 million flowed out of the stock on the tick-down, for a money net flow of ... Mideast Time, 1 day ago

ELI LILLY : Lilly, Merck Sign Collaboration Deal

Merck and Eli Lilly and Company reported an oncology clinical trial collaboration to evaluate the safety, tolerability and efficacy of KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, in combination with Lilly compounds in multiple clinical ...
 4 Traders4 days ago Merck enters into clinical trial collaboration with Eli Lilly  Individual.com6 days ago Eli Lilly's Once Flourishing Neuroscience Pipeline Is Literally In Limbo  Seeking Alpha1 week ago Eli Lilly and Company, Merck enter collaboration agreement  Financial Express1 week ago
[x]  

Eli Lilly (LLY) Trading Near $71.21 Support Level

Eli Lilly and Co (http://www.marketintelligencecenter.com/symbol/LLY"LLY) presents a trading opportunity that offers a 2.57% return in just 56 days. A covered call on Eli Lilly at the $72.50 level expiring on Mar. '15 offers an assigned return ...
 Individual.com2 days ago Eli Lilly (LLY) Trading Near $68.28 Support Level  Individual.com1 week ago

NICE recommends Jardiance (empagliflozin) for the treatment of Type 2 Diabetes to improve glycaemic control in adults

Ratings require JavaScript to be enabled. The Boehringer Ingelheim and Eli Lilly Diabetes Alliance announced today that the National Institute for Health and Care Excellence (NICE) has issued its Final Appraisal Determination 1 (FAD) ...
 Medical News Today2 days ago National Institute for Health and Care Excellence (NICE) recommends Jardiance┬«?(empagliflozin) for the treatment of Type 2 Diabetes (T2D) to improve glycaemic control in adults  BusinessWeek3 days ago National Institute for Health & Care Excellence (NICE) recommends..  ADVFN Australia3 days ago NICE set to recommend Boehringer's type 2 diabetes drug Jardiance  Pharma Letter3 days ago
[x]  

Eli Lilly Fulfills the Promise: Up 4.1% Since Last Week's Upgrade

Goldman Sachs upgraded Eli Lilly (NYSE:LLY) from Sell to Neutral a week ago. The shares closed at $72.24, or 4.1% over the $69.38 price of one
 Individual.com3 days ago

SC 13G/A - LILLY ELI & CO (0000059478) (Subject)

Document Format Files Seq Description Document Type Size 1 NONE doc1.htm SC 13G/A 64801 Complete submission text file
 SEC4 days ago
Bio Spectrum Asia

B-MS sign immunotherapy pacts with Lilly

Singapore: Bristol-Myers Squibb (B-MS) and Eli Lilly have entered into a clinical trial collaboration to evaluate the safety and efficacy of BMS' immunotherapy Opdivo (nivolumab) in combination with Lilly's galunisertib (LY2157299) as a potential ...
 Bio Spectrum Asia1 week ago Bristol Myers Squibb : and Lilly Enter Clinical Collaboration Agreement to Evaluate Opdivo nivolumab in Combination with Galunisertib in Advanced Solid...  4 Traders2 days ago BRISTOL MYERS SQUIBB : and Lilly Team in Clinical Collaboration  4 Traders1 week ago Lilly to test combinations with Merck, Bristol-Myers' cancer drugs  Reuters1 week ago

Eli Lilly (LLY) Breaks Through Resistance at $71.23

Shares of Eli Lilly (NYSE:LLY) have bullishly opened above the pivot of $70.33 today and have reached the first resistance level of $71.23. Investors may be interested in a cross of the next upside pivot targets of $71.77
 Individual.com5 days ago

A Pair Trade With Eli Lilly And Johnson & Johnson? Goldman Just Explained Why It's A Solid Idea

View photo . In a recent report, Goldman Sachs analysts provided an idea for a pair trade with Eli Lilly and Co (NYSE: LLY ) and Johnson & Johnson (NYSE: JNJ ). The firm expects to see Eli Lilly deliver better results in 2015 than Johnson & ...
 Yahoo! Finance1 week ago Here Is Goldman Sachs' Potential Pair Trade For 2 Drug Giants  Market Pulse Navigator1 week ago
[x]  
Reuters

AstraZeneca and Eli Lilly start critical clinical trial for Alzheimer's drugs

Companies have initiated a phase II/III study of an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease BS B2B Bureau | London, UK December 2, 2014 Last Updated at 20:09 IST ...
 Business Standard1 month ago AstraZeneca and Lilly move Alzheimer's drug into big trial  Reuters1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less